- Home
- VTMX vs CLDX Comparison
VTMX vs CLDX Comparison
Compare VTMX & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTMX | CLDX |
|---|---|---|
| Founded | 1998 | N/A |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.2B |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VTMX | CLDX |
|---|---|---|
| Price | $34.59 | $39.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $40.00 | ★ $46.60 |
| AVG Volume (30 Days) | 43.5K | ★ 711.7K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $12.22 | $111.39 |
| Revenue Next Year | $11.52 | $235.85 |
| P/E Ratio | $47.91 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $25.59 | $22.10 |
| 52 Week High | $37.41 | $45.14 |
Technical Indicators
Market Signals| Indicator | VTMX | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.79 | 46.50 |
| Support Level | $33.28 | $28.51 |
| Resistance Level | $35.12 | $40.30 |
| Average True Range (ATR) | 0.72 | 1.46 |
| MACD | 0.00 | -0.45 |
| Stochastic Oscillator | 60.48 | 10.99 |
Price Performance
Historical ComparisonAbout VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.